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Abstract
ER stress results in activation of the unfolded protein response and
has been implicated in the development of fibrotic diseases. In this
study, we show that inhibition of the ER stress-induced IRE1a
signaling pathway, using the inhibitor 4l8C, blocks TGFb-induced
activation of myofibroblasts in vitro, reduces liver and skin fibrosis
in vivo, and reverts the fibrotic phenotype of activated myofibro-
blasts isolated from patients with systemic sclerosis. By using
IRE1a/ fibroblasts and expression of IRE1a-mutant proteins lack-
ing endoribonuclease activity, we confirmed that IRE1a plays an
important role during myofibroblast activation. IRE1a was shown
to cleave miR-150 and thereby to release the suppressive effect
that miR-150 exerted on aSMA expression through c-Myb. Inhibi-
tion of IRE1a was also demonstrated to block ER expansion
through an XBP-1-dependent pathway. Taken together, our results
suggest that ER stress could be an important and conserved mech-
anism in the pathogenesis of fibrosis and that components of the
ER stress pathway may be therapeutically relevant for treating
patients with fibrotic diseases.
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Introduction
Fibrosis is characterized by an excessive accumulation of fibrous
connective tissue that typically occurs in response to chronic
inflammation caused by toxic substances, infections, mechanical
injury, or as a result of autoimmune reactions (Darby & Hewitson,
2007; Kramann et al, 2013; Kendall & Feghali-Bostwick, 2014).
Progressive accumulation of connective tissue ultimately leads to
disruption of tissue architecture and organ dysfunction that can
be fatal as seen in end-stage liver disease, kidney disease,
pulmonary fibrosis, and in heart failure. Chronic autoimmune
diseases such as scleroderma, ulcerative colitis, Crohn’s disease,
and rheumatoid arthritis are additional examples of diseases where
fibrosis is a prominent pathological feature (Gilbane et al, 2013; Li
& Kuemmerle, 2014; Pattanaik et al, 2015). Despite that fibrosis can
affect nearly every tissue in the body and is a major cause of
morbidity and mortality in a variety of diseases, there are few
treatments that specifically target the pathogenesis of fibrosis.
Although the etiology and causative mechanisms may vary
widely, fibrosis always involves excessive production and deposi-
tion of collagen and other extracellular matrix proteins by activated
myofibroblasts. Myofibroblasts express alpha-smooth muscle actin
(aSMA) and are formed and activated as part of a repair mechanism
triggered by tissue damage (Kendall & Feghali-Bostwick, 2014).
Several cell types have been shown to serve as progenitors for
myofibroblasts: residential fibroblasts, epithelial cells (through
epithelial-to-mesenchymal transition) as well as blood-borne
mesenchymal progenitor cells called fibrocytes. In the liver, acti-
vated myofibroblasts derived from hepatic stellate cells (HSCs) are
the principal fibroblastic cell type responsible for matrix deposition.
The formation and function of myofibroblasts is promoted by a
number of secreted soluble factors such as cytokines, growth
factors, and matrix-related factors that act in synergy in the develop-
ment of fibrosis (Kramann et al, 2013). TGFb is considered a key
factor that coordinates the interplay between parenchymal cells,
inflammatory cells, and myofibroblasts (Leask & Abraham, 2004).
Accordingly, overexpression of TGFb in transgenic mice results
in multi-organ fibrosis (Sime et al, 1997; Kanzler et al, 1999;
Rahmutula et al, 2013).
Homeostatic regulation of protein folding in the endoplasmic
reticulum (ER) is under the control of three evolutionary conserved
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pathways: IRE1a-XBP-1, PERK-eIF2a, and ATF6 (Schroder &
Kaufman, 2005). These pathways, also referred to as the unfolded
protein response (UPR), are activated in response to ER stress,
which occurs when cells have to cope with an increased burden in
the protein folding machinery. Importantly, the UPR makes life/
death decisions for the cell and the final outcome of ER stress is
either recovery and survival or apoptosis depending on the severity
and duration of ER stress (Sovolyova et al, 2014). All three path-
ways of the UPR form a coordinated reaction to the accumulation of
unfolded proteins and several studies have demonstrated that there
is cross talk between the different pathways (Yamamoto et al, 2004;
Arai et al, 2006; Adachi et al, 2008). ER stress and activation of the
UPR can be caused by mechanical injury, inflammation, genetic
mutations, infections, and oxidative stress, and has been implicated
in diseases that result in fibrotic remodeling of internal organs, such
as chronic liver diseases (Galligan et al, 2012; Shin et al, 2013; Ji,
2014), pulmonary fibrosis (Baek et al, 2012; Tanjore et al, 2012,
2013), kidney fibrosis (Chiang et al, 2011), cardiovascular disease
(Spitler & Webb, 2014), and inflammatory bowel disease (Bogaert
et al, 2011; Cao et al, 2013).
IRE1a is a kinase located in the ER membrane that transmits
information across the ER lipid bilayer (Tirasophon et al, 2000).
Increased ER protein load and presence of unfolded proteins leads to
the dissociation of the ER chaperone GRP78/BiP from IRE1a. The
free IRE1a then dimerize and autophosphorylate, which leads to acti-
vation of the IRE1a ribonuclease domain in the cytosol. Regulated
IRE1a-dependent decay of mRNA (RIDD) reduces both protein trans-
lation and import of proteins into the ER (Hollien & Weissman,
2006). In addition, IRE1a has the ability to splice XBP-1 mRNA,
which is required for the translation of active XBP-1. After transport
into the nucleus, XBP-1 binds to UPR promoter elements to initiate
expression of genes that enhance the ability of the ER to cope with
unfolded proteins, including molecular chaperones like BiP and tran-
scription factors such as CHOP. ER stress is in addition associated
with enlargement of the ER volume, which has been interpreted as
an adaptive mechanism to increase protein folding capacity (Sriburi
et al, 2004).
Besides degrading mRNA (Binet et al, 2013), it was recently
shown that IRE1a also has the ability to degrade microRNAs (miRs)
(Upton et al, 2012). miRs are short noncoding RNA oligonucleotides
consisting of 17–25 nucleotides that generally act to inhibit gene
expression by binding to complementary sequences in the
30-untranslated region of target mRNAs, either to repress mRNA
translation or to induce mRNA cleavage. A number of cellular func-
tions such as proliferation, differentiation, and apoptosis are regu-
lated by miRs, and aberrant miR expression is observed in a variety
of human diseases including fibrosis (Bowen et al, 2013).
Inhibitors that specifically target individual components of the
UPR have recently been developed. The selective inhibitor 4l8C that
stably binds to lysine 907 in the IRE1a endoribonuclease domain
has been shown to inhibit both RIDD activity and XBP-1 splicing
(Cross et al, 2012). High levels of 4l8C cause no measurable toxic-
ity in cells and concentrations ranging from 80 to 128 lM of 4l8C
completely block XBP-1 splicing without affecting IRE1a kinase
activity (Cross et al, 2012). The inhibitor 4l8C thus represents both
a potential drug and an important tool to delineate the functions of
IRE1a in vivo as IRE1a-knockout mice die during embryonic
development.
In this report, we show that inhibition of IRE1a prevents acti-
vation of myofibroblasts and reduces fibrosis in animal models
of liver and skin fibrosis. Our finding that pharmacological
inhibition of IRE1a could revert the profibrotic phenotype of acti-
vated myofibroblasts isolated from patients with scleroderma
indicates that ER stress inhibitors should be taken into considera-
tion when developing new strategies for the treatment of fibrotic
diseases.
Results
The RNase activity of IRE1a is required for activation
of myofibroblasts
Enhanced secretion of extracellular matrix proteins as well as
increased aSMA expression are typical features of fibroblast to
myofibroblast conversion (Baum & Duffy, 2011). Treatment of
human fetal lung fibroblasts (HFL1) with TGFb resulted in forma-
tion of myofibroblasts as judged by the increased expression of
aSMA (Fig 1A) and collagen I (Fig 1B). Since increased collagen I
production may increase the protein folding demand and activate
the UPR, we measured the expression of several ER stress pathway
components and found increased mRNA expression of CHOP and
BiP (Fig 1C) as well as increased protein levels of CHOP (Fig 1D)
and increased splicing of XBP-1 (Fig 1C and E). To investigate
whether this activation of ER stress, and specifically the activation
of IRE1a, is involved in myofibroblast activation, we inhibited
IRE1a function using the inhibitor 4l8C, which blocked
TGFb-induced activation of fibroblasts as measured by expression of
mRNA and protein levels of aSMA (Fig 1A and F) and collagen I
(Fig 1B and G). Further, TGFb-induced expression of aSMA mRNA
was reduced in cells overexpressing two different mutant forms of
IRE1a that lack RNase activity (Fig 1H) or when complete loss-of-
function experiments were performed using IRE1a/ MEF cells
(Fig 1I).
miR-150 exhibits anti-fibrotic effects and is directly
cleaved by IRE1a
IRE1a has recently been shown to directly cleave miRs (Upton et al,
2012) and it was therefore hypothesized that 4l8C could modulate
fibrosis by preventing cleavage of miRs involved in activation of
myofibroblasts. Decreased levels of miR-29 (Khalil et al, 2015),
miR-148 (Van Keuren-Jensen et al, 2015), and miR-150 (Honda
et al, 2013; Zheng et al, 2013) have been implicated in fibrotic
tissue remodeling and were therefore selected for analysis. The
combined treatment of HFL1 fibroblasts with TGFb and 4l8C led to
a significant increase in miR-150 (Fig 2A), while the levels of miR-
29 and miR-148 were unaffected (Fig EV1). These results suggested
that an IRE1a-dependent signaling pathway could be responsible for
regulating the levels of miR-150. This was further supported by the
finding that overexpression of RNase inactive IRE1a mutants in
HFL1 fibroblasts resulted in increased levels of miR-150 in response
to TGFb (Fig 2B). Further, miR-150 levels were also higher in TGFb-
treated IRE1a/ MEF cells, as compared to WT cells (Fig 2C). To
further investigate whether IRE1a-mediated cleavage of miR-150
contributes to TGFb-induced myofibroblast activation, IRE1a/
EMBO Molecular Medicine ª 2016 The Authors
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Figure 1. The RNase activity of IRE1a is required for activation of myofibroblasts.
A aSMA mRNA levels in TGFb-treated HFL1 fibroblasts and the effect of the IRE1a inhibitor 4l8C. *P = 0.001.
B Collagen 1a2 mRNA levels in TGFb-treated HFL1 fibroblasts  the IRE1a inhibitor 4l8C. *P = 0.01.
C mRNA levels of ER stress-related genes in TGFb-treated HFL1 fibroblasts. *P CHOP = 0.045, *P Bip = 0.023, *P spliced XBP-1 P = 0.001, compared to corresponding
control.
D Western blot of CHOP protein levels in TGFb-treated HFL1 cells  the IRE1a inhibitor 4l8C.
E Agarose gel showing the presence of spliced and unspliced XBP-1 mRNA in TGFb-treated HFL1 fibroblasts  the IRE1a inhibitor 4l8C.
F Immunohistochemical staining of aSMA in TGFb-treated HFL1 fibroblasts  the IRE1a inhibitor 4l8C. Scale bars = 20 lm.
G Quantification of secreted soluble collagen proteins produced by TGFb-treated HFL1 cells  the IRE1a inhibitor 4l8C. *P = 0.049.
H aSMA mRNA expression in TGFb-treated HFL1 cells overexpressing two RNase-dead mutants (K599A and K907A) of IRE1a. *P K599A = 0.013, *P K907A = 0.0008
compared to WT.
I aSMA mRNA expression in TGFb-treated IRE1a/ or WT MEF cells. *P = 0.025.
Data information: Statistical significance was evaluated using Student’s t-test. Significant differences are indicated with * and exact P-values are given. Error bars
indicate s.e.m. n = 3 in (A–C) and (G–I).
Source data are available online for this figure.
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MEF cells were transfected with an anti-miR-150-5p miRNA inhi-
bitor, which was shown to suppress the levels of miR-150 (Fig 2D)
and to increase aSMA mRNA in response to TGFb (Fig 2E). Based
on this, it was hypothesized that miR-150 is directly involved in the
negative regulation of aSMA expression.
The transcription factor c-Myb represents the top target gene of
miR-150 with 3 conserved miR-150 binding sites in the human
mRNA according to TargetScan (Lewis et al, 2003). Several studies
have shown that miR-150 suppresses c-Myb expression (Lin et al,
2008; Feng et al, 2014; Yang et al, 2015) and c-Myb in turn is
known to increase aSMA expression (Kitada et al, 1997; Buck et al,
2000; Zheng et al, 2013). We therefore investigated whether
miR-150 could regulate c-Myb and aSMA expression in HFL1 fibrob-
lasts. Transfection of HFL-1 fibroblasts with a miR-150 expression
plasmid (Fig 2F) resulted in reduced c-Myb and aSMA protein
expression (Fig 2G and H) supporting an anti-fibrotic function of
miR-150. To further establish the link between c-Myb and aSMA,
HFL1 fibroblasts were transfected with siRNA targeting c-Myb
(Fig 2I). In line with previous studies (Kitada et al, 1997; Buck et al,
2000; Zheng et al, 2013), silencing of c-Myb reduced TGFb-induced
aSMA expression (Fig 2J).
Sequence analysis of pre-miR-150 showed the presence of several
putative IRE1a cleavage sites, including one positioned 10 bp from
the 50-terminus (Fig 2K). The possibility that IRE1a may directly
cleave miR-150 was investigated using an in vitro cleavage assay,
with 32P-labeled pre-miR-150 as a substrate and a synthetic stem-
loop RNA corresponding to the XBP-1 substrate as a positive
control. It was found that recombinant IRE1a cleaved pre-miR-150,
which generated a small cleavage product of approximately 10 bp
(Fig 2L). Cleavage of pre-miR-150 and the XBP-1 stem-loop control
was almost completely inhibited by addition of 4l8C, which con-
firmed that 4l8C is an inhibitor of IRE1a RIDD activity (Fig 2L).
Next, HFL1 cells were pre-treated with TGFb and 4l8C, and
transcription inhibited using actinomycin D for 4 and 24 h to see
whether the stability of miR-150 was affected. Indeed, 4l8C was
shown to slow down miR-150 degradation in TGFb-treated
HFL1-cells (Fig 2M). Thus, degradation of miR-150 can be directly
mediated by IRE1a, and loss of IRE1a RNase activity results in
increased levels of miR-150, which results in c-Myb suppression and
reduced TGFb-induced aSMA gene expression.
ER expansion in myofibroblasts is coupled to XBP-1 splicing
Activation of UPR pathways, in particular splicing of XBP-1, has
been linked to ER expansion and increased secretory capacity
(Sriburi et al, 2004; Bommiasamy et al, 2009). Therefore, we
hypothesized that ER stress, through splicing of XBP-1 by IRE1a,
mediates ER expansion and is at least partially required for
TGFb-induced activation of myofibroblasts and secretion of extracel-
lular matrix. TGFb-stimulation of HFL1 fibroblasts resulted in an
enlargement of the ER (Fig 3A and B) in agreement with previous
studies on myofibroblasts (Baum & Duffy, 2011). Treatment of cells
with 4l8C inhibited TGFb-induced ER expansion suggesting a
central role of IRE1a (Fig 3A and B). To specifically investigate the
role of XBP-1, we treated HFL1 fibroblasts with siRNA targeting
XBP-1, which caused an 85% reduction in XBP-1 gene expression
(Fig 3C) and inhibited TGFb-induced ER expansion (Fig 3A and B),
as well as collagen secretion (Fig 3D). These observations suggest
that the IRE1a-XBP-1 axis contributes to myofibroblast activation by
expanding the ER in order to cope with increased protein folding
demands.
Pharmacological inhibition of IRE1a attenuates liver fibrosis
The UPR is activated in several liver diseases (Malhi & Kaufman,
2011). To investigate whether inhibition of IRE1a could reduce
development of liver cirrhosis, we used a mouse model in which
hepatic fibrosis was induced by alcohol and CCl4 (Geerts et al,
2008). Mice developed typical bridging liver fibrosis with an
increased METAVIR score reflecting F3-F4 cirrhosis (Bedossa &
Poynard, 1996) (Fig 4A and B). Treatment with 4l8C reduced
fibrosis (Fig 4A and B) and the number of aSMA-positive
▸Figure 2. miR-150 exhibits anti-fibrotic effects and is directly cleaved by IRE1a.A miR-150 levels in TGFb-treated HFL1 fibroblasts and the effect of the IRE1a inhibitor 4l8C. *P = 0.046 compared to control.
B miR-150 levels in HFL1 fibroblasts overexpressing two RNase-dead mutants (K599A and K907A) of IRE1a. *P = 0.0043 (K599A), P = 0.043 (K907A), compared to control.
C miR-150 levels in TGFb-treated WT (IRE1a +/+) and IRE1a / MEF cells. *P = 0.018. Results are expressed as fold change compared to the Ctrl.
D miR-150 levels in IRE1a / MEF cells that were either untransfected (UT) or transfected with miRNA inhibitor control (siCtrl) or with a miR-150-5p miRNA inhibitor.
*P = 0.034 compared to UT.
E aSMA mRNA expression in TGFb-treated IRE1a / MEF cells that were either untransfected (UT) or transfected with miRNA inhibitor control (siCtrl) or with a miR-
150-5p miRNA inhibitor. *P = 0.043 compared to UT.
F miR-150 levels in HFL1 fibroblasts transfected with a control plasmid (Ctrl) or a miR-150 expression plasmid (miR-150). *P = 0.038.
G Western blot of c-Myb in TGFb-treated HFL1 fibroblasts that were either untransfected (UT), transfected with a control plasmid (pCtrl) or a miR-150 expression
plasmid (miR-150). *P = 0.0206 in UT Ctrl versus UT TGFb and P = 0.0126 in pCtrl Ctrl versus pCtrl TGFb.
H Western blot of aSMA in the same experimental setup as in (G). *P = 0.0405 in UT Ctrl versus UT TGFb, and P = 0.0284 in pCtrl Ctrl versus pCtrl TGFb.
I c-Myb mRNA levels in untransfected HFL1 cells (UT) and in cells transfected with a control siRNA (siCtrl) or an siRNA targeting c-Myb (sicMyb). *P = 0.00001
compared to UT.
J aSMA mRNA expression in untransfected HFL1 cells (UT) and in cells transfected with a control siRNA (siCtrl) or with a siRNA targeting c-Myb (sicMyb). *P = 0.0042
in UT Ctrl versus UT TGFb.
K Putative IRE1a cleavage sites in miR-150 based on sequence analysis are indicated with arrows.
L In vitro cleavage assay with recombinant IRE1a and miR-150 (left) or XBP-1 (right).
M miR-150 expression in HFL-1 cells that were pre-treated with TGFb in the absence of presence of 4l8C and then treated with actinomycin D (ActD) for 4 and 24 h.
*P = 0.027 compared to TGFb.
Data information: Statistical significance was evaluated using Student’s t-test. Significant differences are indicated with * and exact P-values given. Error bars indicate
s.e.m. n = 3 in (A–E, G–J, M) and n = 4 in (F).
Source data are available online for this figure.
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myofibroblasts in pericentral areas (Fig 4C). Fibrotic livers typi-
cally have an increased size and weight and treatment with 4l8C
decreased the liver-to-body weight ratio to further support the
hypothesis that inhibition of the UPR reduces disease progression
(Fig 4D). To verify that 4l8C affected activation of the UPR, mark-
ers of the UPR pathway were measured. The mRNA levels of BiP
A
B C D
Figure 3. ER expansion in myofibroblasts is coupled to XBP-1 splicing.
A Analysis of ER size in HFL1 fibroblasts treated with TGFb in the absence (Ctrl) or presence of the IRE1a inhibitor 4l8C, or in HFL1 cells transfected with a siRNA
control siRNA (siCtrl) or with siRNA targeting XBP-1 (siXBP-1). The ER was visualized with ER-Tracker Red and nuclei stained with Hoechst (left, scale bars = 20 lm)
or by electron microscopy (right, scale bars = 200 nm) where red lines mark the ER.
B Quantification of ER size relative to the nucleus from the experimental setup in (A). *P = 0.0001 in Ctrl, and *P = 0.0223 in siCtrl.
C XBP-1 mRNA expression in untransfected HFL1 cells (UT) and in cells transfected with control siRNA (siCtrl) or siRNA targeting XBP-1 (siXBP-1). *P = 0.0001.
D Collagen protein levels in TGFb-treated HFL1 fibroblasts transfected as described in (C). *P = 0.005.
Data information: Statistical significance was evaluated using Student’s t-test. Significant differences are indicated with * and exact P-values given. Error bars indicate
s.e.m. n = 3 in (B, C) and n = 4 in (D).
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(Fig 4E) and splicing of XBP-1 (Fig 4F) were reduced in livers from
mice treated with 4l8C. In support of a model where miR-150
exerts anti-fibrotic effects, we found that miR-150 levels
were increased in liver tissue isolated from 4l8C-treated mice
(Fig 4G).
Immunohistochemical staining of liver sections showed co-locali-
zation of the myofibroblast marker aSMA with the UPR markers BiP
and CHOP, which suggests that activated HSCs were contributing to
the observed increased activation of the UPR (Fig EV2A and B). In
addition, HSCs were isolated from mice and in vitro treatment with
4l8C inhibited TGFb-induced expression of aSMA and BiP (Fig 4H–K)
indicating that the fibrosis-reducing effect of 4l8C is by inhibition of
ER stress and reduced activation of HSCs. Similarly, 4l8C inhibited
TGFb-induced collagen I and connective tissue growth factor
(CTGF) mRNA expression in HSCs isolated from human liver
(Fig 4L). These results suggest that inhibition of IRE1a RNase
activity can attenuate liver fibrosis by hindering HSCs to become
activated myofibroblasts.
Inhibition of IRE1a reduces skin fibrosis
In order to investigate whether interference with ER stress at the
level of IRE1a affects fibrosis in other models, and hence could be
of more general applicability, we used a mouse model of skin
fibrosis where TGFb is continuously infused through subcuta-
neously implanted mini-osmotic pumps. TGFb caused a fibrotic
response in the hypodermis with an increased number of activated
aSMA-expressing myofibroblasts, together with an increased
amount of deposited collagen, which was significantly decreased in
4l8C-treated mice (Fig 5A–C). Selective analysis of the hypodermis
by laser capture microdissection (Fig 5D) confirmed that treatment
with 4l8C reduced aSMA mRNA expression (Fig 5E) and a
tendency toward increased miR-150 levels (Fig 5F). Staining of skin
sections from TGFb-treated mice showed co-localization of the
myofibroblast marker aSMA with the UPR markers BiP and CHOP
in the hypodermis, which confirms activation of the UPR in
myofibroblasts (Fig EV3A and B). Treatment of primary mouse skin
fibroblasts with 4l8C similarly inhibited TGFb-induced aSMA
expression (Fig 5G and H) and 4l8C also decreased activation of the
UPR (Fig 5I–K) and increased the level of miR-150 (Fig 5L). This
further supports that 4l8C inhibits fibrosis by preventing activation
of myofibroblasts.
The fibrotic phenotype of myofibroblasts isolated from patients
with scleroderma can be reverted by inhibition of IRE1a
Scleroderma, or progressive systemic sclerosis (SSc), is a connec-
tive tissue disease characterized by severe multi-organ fibrosis,
which results from the excessive synthesis of extracellular matrix
by myofibroblasts (Gilbane et al, 2013). To explore the possibility
that IRE1a could be a potential therapeutic target for treatment of
SSc, fibroblasts isolated from SSc patients were treated with
4l8C. These experiments showed that pharmacological inhibition
of IRE1a significantly decreased mRNA levels of CTGF (Fig 6A)
and collagen I (Fig 6B) and soluble collagen protein expression
(Fig 6C) in fibroblasts from both skin (dSSc) and lung (LSSc).
Fibroblasts from SSc patients also showed increased levels of BiP,
which were reduced after treatment with 4l8C (Fig 6D). To
further study the general applicability of treatment with 4l8C,
primary lung fibroblasts from patients with inflammatory lung
diseases, such as cystic fibrosis (CF), chronic obstructive
pulmonary disease (COPD), and asthma, were exposed to 4l8C.
CF, COPD, and asthma are diseases that cause chronic inflamma-
tion of the airways, involving myofibroblast activation and ECM
deposition. Primary fibroblasts from asthma patients, but not
fibroblasts isolated from CF or COPD patients, expressed signifi-
cantly increased levels of aSMA and BiP compared to controls,
which were decreased by treatment with 4l8C (Fig 6E and F).
These results suggest that inhibition of IRE1a not only can
prevent formation and activation of myofibroblasts, but also can
revert the fibrotic phenotype of myofibroblasts in cells isolated
from patients with fibrotic disease.
Discussion
There is increasing evidence that ER stress and activation of the
UPR is a feature of fibrosis in different organs caused by different
etiologies. On a cellular level, the myofibroblast is considered to
have a central role in development of fibrosis, but little is known
Figure 4. Pharmacological inhibition of IRE1a attenuates liver fibrosis.
A The effect of the IRE1a inhibitor 4l8C on CCl4-induced liver fibrosis in C57BL/6 mice as measured by the histological METAVIR score. Ctrl (n = 8); Ctrl + 4l8C (n = 6);
CCl4 (n = 6); CCl4 + 4l8C (n = 8). *P = 0.0077.
B Representative liver tissue sections stained with sirius red for collagen (top) and aSMA (bottom). Scale bars = 50 lm.
C Percentage of aSMA-positive cells in pericentral areas in livers from mice in the experimental setup in (A). *P = 0.036.
D Liver-to-body weight ratio from the experimental setup in (A). *P = 0.0031. Ctrl (n = 8); Ctrl + 4l8C (n = 6); CCl4 (n = 6); CCl4 + 4l8C (n = 8).
E BiP mRNA expression in liver tissue from mice presented in (A). *P = 0.020. Ctrl (n = 5); Ctrl + 4l8C (n = 5); CCl4 (n = 5); CCl4 + 4l8C (n = 5).
F Representative gel showing levels of spliced and unspliced XBP-1 in liver tissue from control and CCl4-induced cirrhotic mice and the effect of 4l8C treatment.
G miR-150 expression in liver tissue from mice in (A). *P = 0.032 compared to untreated controls. Ctrl (n = 5); Ctrl + 4l8C (n = 5); CCl4 (n = 5); CCl4 + 4l8C (n = 5).
H aSMA mRNA levels in primary stellate cells isolated from mouse liver and then treated or not with TGFb  4l8C. *P = 0.031, n = 3.
I BiP mRNA levels in primary stellate cells isolated from mouse liver and then treated with or without TGFb  4l8C. *P = 0.008, n = 3.
J Microscopic images of primary mouse hepatic stellate cells stained for BiP (top) or aSMA (bottom). Scale bars = 20 lm.
K Western blot showing BiP protein expression in primary mouse hepatic stellate cells.
L Quantification of mRNA expression levels of CTGF and collagen in primary human hepatic stellate cells stimulated with TGFb 4l8C.
Data information: Statistical significance was evaluated using Student’s t-test. Significant differences are indicated with * and exact P-values given. Error bars
indicate s.e.m.
Source data are available online for this figure.
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about how ER stress influences the activation of fibroblasts to
myofibroblasts. It has been shown that treatment of fibroblasts
with TGFb induces ER stress and formation of myofibroblasts,
which could be inhibited with a chemical chaperone that inhibits
ER stress by improving the ER protein folding capacity (Baek
et al, 2012). In this report, we further define a direct role of
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the UPR in myofibroblast differentiation as we provide evidence
that inhibition of IRE1a prevents TGFb-induced formation of
myofibroblasts.
The recent finding that IRE1a is capable of degrading miRs, in
addition to its well-known ability to degrade mRNA, provides a
new possible connection between IRE1a and miRs that regulate
the activation of myofibroblasts (Upton et al, 2012). IRE1a, miRs,
and components of the RISC machinery are found on the cytosolic
side of the rough ER membrane (Daniels et al, 2009; Li et al,
2013; Stalder et al, 2013), which would allow a direct interaction
between IRE1a and miRs. Sequence analysis of miR-150 revealed
several putative IRE1a cleavage sites (-TGCT-) (Upton et al, 2012)
and our data demonstrate that IRE1a directly cleaves miR-150,
providing a mechanism for the increased levels of miR-150 that
were observed when IRE1a was inhibited in TGFb-treated fibrob-
lasts. Cleavage of pre-miR-150 by IRE1a probably destabilizes pre-
miR-150 to prevent further processing by Dicer, as described for
another ribonuclease, MPCP1 (Suzuki et al, 2011). Previous stud-
ies on isolated HSCs have similarly shown that TGFb reduces miR-
150 levels and that overexpression of miR-150 inhibits TGFb-
induced aSMA and collagen I and IV expression (Buck et al, 2000;
Zheng et al, 2013). These results in combination with reports that
miR-150 is decreased in fibrotic conditions and correlates with
disease severity (Honda et al, 2013) indicate an anti-fibrotic func-
tion of miR-150.
One of the top target genes of miR-150 is the transcription factor
c-Myb (Lin et al, 2008; Feng et al, 2014; Yang et al, 2015). c-Myb is
known to bind the aSMA promoter and overexpression of c-Myb in
HSCs increases aSMA expression, while antisense c-Myb inhibits
aSMA expression (Buck et al, 2000). In addition, miR-150 has been
shown to regulate collagen I expression by regulating the transcrip-
tion factor SP1 (Zheng et al, 2013). These findings would suggest a
pathway where fibrosis-inducing agents like TGFb induce ER stress
with activation of IRE1a. Activated IRE1a then degrades miR-150,
removing the inhibitory effect of miR-150 on expression of tran-
scription factors like c-Myb and SP1. Increased levels of these
transcription factors are essential for the formation of myofibro-
blasts as they induce expression of aSMA and collagen I. Under
normal conditions, miR-150 would continuously suppress
expression of profibrotic transcription factors and prevent formation
of myofibroblasts.
A similar mechanism whereby activated IRE1a inactivates miRs
that normally repress protein translation has been demonstrated for
other biological responses. For example, it has previously been
shown that increased caspase-2 expression and induction of
apoptosis can be a result of IRE1a activation leading to destruction
of miRs that under normal conditions repress caspase-2 expression
(Upton et al, 2012). Suppression of these miRs increased caspase-2
without any additional stimuli. Further, another study showed that
the thioredoxin-interacting protein (TXNIP) is increased as a result
of activated IRE1a destroying miR-17 that otherwise mediates
degradation of TXNIP mRNA (Lerner et al, 2012).
In a parallel pathway, we observed an IRE1a- and XBP-1-
dependent increase in ER size when fibroblasts were stimulated
with TGFb. An enlarged ER would prepare the myofibroblast for
increased production and folding of extracellular matrix proteins
during wound healing and fibrosis. It has been suggested that
splicing and hence activation of XBP-1 in response to ER
stress promotes an increase in ER volume through increased
phospholipid biosynthesis in the ER membrane (Sriburi et al,
2004). A functional role of XBP-1 in membrane biogenesis was
originally described for differentiation of B lymphocytes into anti-
body-secreting plasma B cells (Reimold et al, 2001) and later also
for ER expansion in pancreatic b-cells (Lee et al, 2005) and in
hepatocytes (Lee et al, 2008).
In conclusion, our study indicates that activation of the UPR is
a conserved mechanism in fibrotic pathologies in various organs
and that targeting the IRE1a RNase activity with the inhibitor
4l8C could be a potential treatment strategy for patients with
progressive fibrotic diseases. We suggest that there are two mecha-
nisms by which IRE1a contributes to myofibroblast activation
(Fig 7). Firstly, the RIDD activity of IRE1a is responsible for
degrading the anti-fibrotic miR-150 to allow for increased c-Myb
activity leading to increased aSMA expression, thereby resulting in
increased formation of myofibroblasts. Secondly, IRE1a mediates
splicing of XBP-1, leading to ER expansion that contributes to the
enhanced secretory capacity needed for the secretion of extracellular
matrix proteins.
Figure 5. Inhibition of IRE1a reduces skin fibrosis.
A The effect of the IRE1a inhibitor 4l8C on TGFb-induced skin fibrosis in C57BL/6 mice as measured by the percentage of sirius red areas in the hypodermis.
Ctrl (n = 6); Ctrl + 4l8C (n = 5); TGFb (n = 8); TGFb + 4l8C (n = 8). *P = 0.046.
B Representative skin tissue sections stained with sirius red for collagen (top) and aSMA (bottom). Scale bars = 50 lm.
C Percentage of aSMA-positive cells in the hypodermis of mice from the experimental setup in (A). *P = 0.024.
D Representative image of the area selected for laser capture microdissection (scale bars = 100 lm).
E Expression levels of aSMA mRNA in samples of hypodermis obtained by laser capture microdissection. Ctrl (n = 5), Ctrl + 4l8C (n = 5), TGFb (n = 5), TGFb + 4l8C
(n = 5). *P = 0.044.
F miR-150 expression levels in the same samples as shown in (E).
G Immunohistochemical staining of aSMA in primary skin fibroblasts isolated from healthy mice after treatment with TGFb  4l8C. Scale bars = 20 lm.
H aSMA mRNA expression in primary mouse skin fibroblasts after treatment with TGFb  4l8C. *P = 0.049, n = 4.
I Agarose gel showing levels of spliced and unspliced XBP-1 in primary mouse skin fibroblasts treated as indicated with TGFb and 4l8C.
J BiP mRNA expression in primary mouse skin fibroblasts after treatment with TGFb in the absence and presence of 4l8C. *P = 0.00007 for TGFb versus Ctrl and
P = 0.00002 for TGFb versus TGFb + 4l8C. n = 4.
K Western blot showing CHOP protein expression in primary mouse skin fibroblasts treated as indicated with TGFb and 4l8C.
L miR-150 mRNA levels in primary mouse skin fibroblasts treated as indicated with TGFb and 4l8C. *P = 0.00031 compared to untreated control, n = 3.
Data information: Statistical significance was evaluated using Student’s t-test. Significant differences are indicated with * and exact P-values given. Error bars
indicate s.e.m.
Source data are available online for this figure.
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Figure 6. Inhibition of IRE1a reverts the fibrotic phenotype of myofibroblasts isolated from scleroderma patients.
A CTGF mRNA expression levels in skin (dSSc) and lung (LSSc) fibroblasts isolated from scleroderma patients and treated with the IRE1a inhibitor 4l8C. *P = 0.018 for
dSSc (n = 6) and P = 0.003 for LSSc (n = 3).
B Collagen 1a2 mRNA expression levels in the same samples as in (A). *P = 0.0030 for dSSc and P = 0.0036 for LSSc.
C Quantification of collagen protein levels in the same samples as in (A). *P = 0.010.
D Immunohistochemical staining to detect BiP protein in fibroblasts isolated from scleroderma patients treated or not with 4l8C. Scale bars = 20 lm.
E mRNA levels of aSMA in primary lung fibroblasts isolated from patients with either cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), or asthma.
*P = 0.00001 for asthma versus healthy controls, and P = 0.00003 for ctrl versus 4l8C in asthma patients.
F Quantification of mRNA levels for BiP in same samples as in (E). *P = 0.0023 between asthma and healthy controls and P = 0.0031 between 4l8C-treated and
control treatment in fibroblasts from asthma patients.
Data information: Statistical significance was evaluated using Student’s t-test. Significant differences are indicated with * and exact P-values given. Error bars indicate
s.e.m. n = 3 in (E, F).
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Materials and Methods
Cell culture and reagents
Human fetal lung fibroblast (HFL1, ECACC) was routinely cultured
in MEM supplemented with nonessential amino acids, 25 mM
HEPES (Sigma), 10% FBS (Gibco), 2 mM glutamax (Gibco), and
1 mM sodium pyruvate (Gibco). Cells were cultured at 37°C with
5% CO2. For starvation, stimulation and migration growth medium
without FBS was used.
Primary cells were isolated from skin and lung, using the tissue
explant outgrowth method. Shortly, fresh tissue was obtained post-
mortem from adult mice, rinsed in PBS, cut in 5-mm2 pieces, and
subsequently added to culture plates with medium (DMEM, 10%
FCS, penicillin, streptomycin, and fungizone) to allow outgrowth of
fibroblasts. Mouse hepatic stellate cells were isolated using a
pronase/collagenase digestion, followed by Nycodenz gradient
centrifugation (Maschmeyer et al, 2011). Human hepatic stellate
cells were isolated as previously described (Rombouts et al, 2012).
Fibroblasts were explanted and cultured from skin or lung tissue
taken from patients with scleroderma or from normal control
subjects (kind gift of Prof Chris Denton, Royal Free Hospital UK).
The patients fulfilled the American College of Rheumatology crite-
ria. All samples were obtained after informed consent and under
institutional local research ethics committee approval (Royal Free
and Medical School Local Research Ethics Committee) (Ponticos
et al, 2015). Each of the primary cell lines in this study is derived
from a different individual or mouse.
Mouse embryonic fibroblasts (MEFs) either WT or deficient for
IRE1a (kind gift from R.J. Kaufman, Sanford-Burnham Institute)
were grown in DMEM media supplemented with 10% fetal bovine
serum. Primary lung fibroblasts from patients with asthma (194912,
Lonza), COPD (195277, Lonza), and CF (194843, Lonza) and
healthy controls (CC-2512; Lonza) were grown in FGM-2 medium
(CC3131 and CC4134, Lonza).
For in vitro experiments, cells were detached using trypsin–
EDTA (Gibco), resuspended in growth medium, and plated at a
density of 5 × 103 cells/cm2. Cells were allowed to attach and left
undisturbed for 8 h before being starved for 16 h. After that time,
fresh starvation medium containing indicated growth factors or
substances was added. Cells were exposed for 48 h to 5 ng/ml
TGFb and/or 100 lM 4l8C, unless stated otherwise. Previous
studies have shown that concentrations up to 128 lM of 4l8C
cause no measurable toxicity and that a concentration of 100 lM
leads to a complete inhibition of XBP-1 splicing (Cross et al,
2012). Actinomycin D (A1410, Sigma) was added to the cells at a
concentration of 5 lg/ml.
miR cleavage assay
Pre-miR-150 was synthesized by Thermo Fisher Scientific miRIDIAN
using the published sequence in the miRBase (www.mirbase.org).
The dephosphorylated pre-miRNA was end-labeled with 32P-ATP
and incubated with 2.5 lg of recombinant IRE1a for 6 h at 37°C in a
reaction buffer (20 mM Hepes, 50 mM NaCl, 1 mM DTT, 10 mM
ATP). Cleaved products were resolved using a 15% denaturing poly-
acrylamide gel. The dried gel was exposed to an autoradiographic
film overnight. The XBP-1 mini-stem loop was synthesized by Inte-
grated DNA Technologies and processed similarlyto pre-miR-150.
The pre-miR-150 and XBP-1 mini-stem-loop sequences are provided
in Table EV1.
Quantitative RT–PCR of mRNA or miRNA and XBP-1 splicing assay
RNA was isolated from tissue or cell culture using the Qiagen
miRNeasy Mini kit according to the manufacturer’s instructions.
Briefly, 500 ng of miRNA/mRNA was reverse-transcribed using
miScript II RT Kit, and amplifications performed using primers
summarized in Table EV2. Normalization was done using
ActB/RPS18/TBP for mRNA and SNORD68/SNORD95 for miRNA.
The spliced form of XBP-1 was detected by incubation of the semi-
quantitative PCR product with PstI enzyme for 3 h at 37°C (Calfon
et al, 2002). The upper, undigested product corresponds to XBP-1
spliced variant as seen following migration in a 1.5% agarose gel.
Transfections and nucleofections
HFL1 cells were transiently transfected with 300 ng of IRE1a WT,
K599A or K907A, and miR-150 expression plasmid (in courtesy of
D. Bartel, Addgene #26310) using Lipofectamine LTX and the PLUS
reagent for 24 h. Nucleofection of siXBP-1 (sc-38627, Santa Cruz),
sic-Myb (4392420, Life Technologies), si-miR-150 (219300, Qiagen),
or siCtrl (100 pmol) was done using Amaxa Nucleofector program
S-05 in Ingenio electroporation solution (Mirus Bio LLC). Cells were
starved overnight and subsequently treated with 5 ng/ml TGFb
and/or 4l8C (100 lM) for 48 h.
XBP1
miR-150
OFF ON
ER stress
cMyb
ECM synthesis
ER expansion
Spliced XBP1
Cleaved miR-150
αSMA
cMyb
4μ8CIRE1αIRE1α
Figure 7. Model for the role of IRE1a in myofibroblast activation.
In the absence of ER stress, miR-150 inhibits c-Myb expression to prevent
c-Myb-induced aSMA expression. ER stress, for example, as a result of fibrotic
stimuli, activates IRE1a that directly cleaves and inactivates miR-150 resulting in
increased c-Myb expression and as a consequence increased expression of aSMA
and activation of myofibroblasts. In addition, IRE1a-mediated splicing of XBP-1
mRNA leads to ER expansion and enhanced secretory capacity of extracellular
matrix proteins. Inhibition of the endoribonuclease activity of IRE1a by 4l8C will
lead to increased miR-150 levels followed by reduced c-Myb and aSMA levels.
Treatment with 4l8C will also reduce XBP-1 splicing, ER expansion, and
secretion of matrix proteins.
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Animal experiments
Eight-week-old, male C57Bl/6 mice were obtained from Scanbur
(Denmark). Mice were housed in standard conditions with normal
dark–light cycle. Animals were acclimatized to their environment
for 1 week and given ad libitum access to water and food through-
out the experiments. Mice were randomly divided into different
treatment groups prior to starting the experiment. During experi-
ments, mice were weighted twice per week and their health was
evaluated using the Karolinska Institute health monitoring template,
whereby a total score of > 0.4 or a single score of > 0.3 was consid-
ered a humane endpoint for euthanasia. Sample size was deter-
mined from previous experience (Geerts et al, 2008; Van de Veire
et al, 2010; Van Steenkiste et al, 2011).
Skin fibrosis model
Mini-osmotic pumps (Alzet 1003D, 1 ll/h) containing TGFb
(200 ng in 0.1% BSA in saline) or controls (0.1% BSA in saline)
were implanted subcutaneous in 32 mice under isoflurane (Forane)
anesthesia. Postoperative analgesia (Temgesic) was provided daily
for 3 days. Mice were subcutaneously injected every day near the
implantation site with 10 lg/g 4l8C in saline or 0.08% DMSO in
saline (control). Skin biopsies were collected after 3 days using
4-mm biopsy punches.
Liver cirrhosis model
Sixteen mice were injected twice per week with CCl4 (Sigma) (1:1
dissolved in olive oil; 1 mg/kg) and 5% alcohol was added to drink-
ing water. Similarly, 16 control mice received physiological saline
solution (1 ml/kg) and no alcohol was added. Mice were injected
twice per week with 10 lg/g 4l8C in saline or 0.08% DMSO in
saline (control). After 15 weeks, mice were euthanized and samples
were taken from the liver.
Stainings and immunohistochemistry
Tissue samples were fixed in 4% paraformaldehyde for 24 h and
subsequently embedded in paraffin. 5-lm slides were cut and
dried overnight. Sections were de-paraffinized and rehydrated
prior to staining. Collagen was stained using the picrosirius red
staining with an incubation time of 30 min, followed by 10-min
washing in distilled water. For the immunohistochemical staining
of aSMA, an antigen retrieval was done at 95°C in sodium citrate
buffer, endogenous peroxidase activity was blocked using 3%
H2O2, and endogenous mouse IgG was blocked using a mouse-on-
mouse staining kit (ab127055, Abcam) prior to a 1-h incubation
with the primary antibody (A2547, Sigma) followed by a HRP-
coupled secondary antibody using DAB as substrate. Slides were
washed in TBS-T (0.1% Triton X-100) 3 × 10 min after primary
and secondary antibody incubations. Slides were counterstained
with Mayer’s hematoxylin. For the immunofluorescent stainings of
skin and liver tissue, antigen retrieval was done at 95°C in sodium
citrate buffer and endogenous mouse IgG was blocked using a
rodent blocking buffer (ab127055, Abcam) following the manufac-
turer’s protocol. Samples were incubated overnight at 4°C with
primary antibodies against aSMA (A2547, Sigma), BiP (ab21685,
Abcam), and/or CHOP (sc575, Santa Cruz). A 20-min incubation
was used for the secondary antibody (Alexa Fluor 488 and Alexa
Fluor 555) and cell nuclei were stained with Hoechst for 5 min.
For staining of cells in culture, cells were fixed for 10 min in 4%
paraformaldehyde, washed with PBS, and blocked for 30 min using
1% BSA in PBS + 0.1% Tween, followed by a 1-h incubation with
antibodies against aSMA (clone 1A4, Sigma) or BiP (ab21685). A
20-min incubation was used for the secondary antibody (Alexa
Fluor 488) and cell nuclei were stained with Hoechst staining for
5 min. Images were acquired using a Nikon eclipse 90i microscope
equipped with a DS-Qi1Mc camera and Nikon Plan Apo objectives.
NIS-Elements AR 3.2 software was used to save and export the
images. The different channels (RGB) of immunofluorescent images
were merged using ImageJ software. Quantifications were
performed blindly with ImageJ software by conversion to binary
images after color de-convolution to separate DAB staining, as
previously described (Ruifrok & Johnston, 2001).
Collagen measurements
Cell culture medium was collected after 48 h of stimulation and the
concentration of soluble collagen was measured using the Sircol
Assay kit (BCS1000, Nordic BioSite, Ta¨by, Sweden) following manu-
facturer’s protocol.
Immunoblotting
Samples were lysed and protein concentrations were determined
using the BCA reagent. Equal amounts of proteins were analyzed by
standard SDS–PAGE technique. Membranes were incubated with
the respective antibodies (see Table EV2) and analyzed using the
Li-Cor Odyssey imaging system.
Laser microdissection
Mouse skin samples were embedded in OCT and cut into 8-lm
sections and mounted on frame slides (POL-Membrane 0.9 lm, Leica
Microsystems, Wetzlar, Germany). Sections were fixed in acetone,
washed with RNase-free water, then stained with RNase-free hema-
toxylin (Arcturus HistoGene Staining Solution, Applied Biosys-
tems, Foster City, CA, USA) for 1 min, dehydrated, and dried. The
hypodermis layer was laser microdissected using a Leica LMD6000 B
microscope. Quantification of mRNA or miRNA expression in the
microdissected layers was performed as previously described.
Quantification of ER expansion
For ER staining, cells were washed once with HBSS and incubated
for 30 min with 1 lm of ER-Tracker Red (Invitrogen). After 5-min
fixation with 3.7% formaldehyde at 37°C, cells were counterstained
with Hoechst and visualized using a Zeiss LSM 700 confocal
microscope. Quantification of ER morphology was done blindly
using ImageJ software. For the electron microscopy images, cells
were fixed in 2% paraformaldehyde with 0.25% glutaraldehyde in
PBS, postfixed in 1% OsO4, and embedded in Epon (Ladd Research
Industries, Burlington, VT, USA). The material was studied at
100 kV in a Jeol 1230 electron microscope (Jeol, Akishima, Tokyo,
Japan). Electron micrographs were taken with a Gatan multiscan
ª 2016 The Authors EMBO Molecular Medicine
Femke Heindryckx et al Endoplasmic reticulum stress enhances fibrosis EMBO Molecular Medicine
13
Published online: May 25, 2016 
camera model 791 with Gatan digital micrograph software version
3.6.4 (Gatan, Pleasanton, CA, USA).
Statistics
Data are presented as mean  s.e.m. An unpaired, two-tailed
Student’s t-test was used to compare different groups; a P < 0.05
was considered statistically different.
Study approval
The ethical committee for animal studies approved all methods
involving animals (C45/13 and C95/14).
Expanded View for this article is available online.
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